Melodiol Global Health Ltd (ASX: ME1) is a global pharmaceutical company specializing in cannabis-derived therapeutic, nutraceutical, and lifestyle products. The company develops a diverse portfolio aimed at advancing health solutions through cannabis-based innovations. It maintains an active presence in the pharmaceutical industry with a focus on global markets.

‌